ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Bone Research
This article is part of the Research TopicMetabolic and Biomechanical Factors in Bone Fragility: New Frontiers in Understanding and Managing OsteoporosisView all 16 articles
Reference intervals for intact FGF 23 in healthy Korean adults: Lower concentrations in young adulthood require age-specific partitioning
Provisionally accepted- 1Hallym University Sacred Heart Hospital, Anyang-si, Republic of Korea
- 2College of Medicine, Yonsei University, Seoul, Republic of Korea
- 3Keimyung University School of Medicine, Dalseo-gu, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Fibroblast growth factor 23 (FGF23) is a bone-derived phosphaturic hormone that is essential for phosphate homeostasis. Elevated FGF23 levels underlie FGF23-related hypophosphatemic rickets and tumor-induced osteomalacia. Despite its clinical importance, population-based reference intervals (RIs) for intact FGF23 using the widely deployed LIAISON XL automated chemiluminescent immunoassay platform (DiaSorin) are lacking for East Asian populations. Methods: We established method-specific RIs for intact FGF23 (iFGF23) in 386 healthy Korean adults (193 males and 193 females; age, 20–79 years) following the Clinical and Laboratory Standards Institute EP28-A3c guidelines. After the Box–Cox transformation and Horn's outlier detection, the RIs were derived using nonparametric methods (2.5th–97.5th percentiles). The necessity for partitioning was assessed using the Harris–Boyd method. Associations between iFGF23 levels and demographic, anthropometric, and biochemical parameters were examined using Pearson's correlation coefficients. Results: The overall nonparametric RI was 28.04–100.33 pg/mL (90% CI: 25.77–31.91 to 96.29–109.20). Age emerged as the primary determinant requiring partitioning, with young adults (20–29 years) exhibiting significantly lower concentrations than older adults (≥30 years): 25.73–78.76 versus 32.01–107.00 pg/mL. A sex-stratified analysis confirmed that this age effect persisted independently in both males and females. Although males had higher median iFGF23 than females (65.03 vs. 51.98 pg/mL, p < 0.001), Harris–Boyd analysis did not support sex-based partitioning (z = 5.17, z* = 5.38). Intact FGF23 was significantly correlated with age (r = 0.278), estimated glomerular filtration rate (r = –0.254), and alkaline phosphatase (r = 0.143; all p ≤ 0.005), but not with traditional mineral metabolism parameters (phosphate, calcium, parathyroid hormone, and 25-hydroxyvitamin D). Conclusions: This study provides the first population-and method-specific RIs for intact FGF23 in an East Asian population and establishes critical age-stratified benchmarks for clinical interpretation. The distinct RI in young adults underscores the necessity of age-appropriate reference standards for diagnosing and monitoring phosphate homeostasis disorders. These findings highlight the importance of population-specific reference data in the absence of assay harmonization.
Keywords: age partitioning, Chemiluminescent immunoassay, Fibroblast growth factor 23, Korean population, mineral metabolism, Reference interval
Received: 23 Oct 2025; Accepted: 16 Feb 2026.
Copyright: © 2026 Cho, Jang, Nam, Jang, Kang, Rim, Lee and Lim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
John Hoon Rim
Jong-Baeck Lim
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
